Details of the Drug Reposition

General Information of This Drug (ID: DM24SOL)

Drug Name
MLN1202   DM24SOL
Synonyms UNNCHYARSNZOPF-UHFFFAOYSA-L; RFI-641; UNII-FR2W015BG1; FR2W015BG1; WAY-154641; CHEMBL425633; SCHEMBL20741446; RF-1461
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Metastatic cancer DISBPS35 2D50-2E2Z Phase 2 [1]
Multiple sclerosis DISB2WZI 8A40 Phase 2 [1]
------------------------------------------------------------------------------------
1 Terminated Indication(s)
Indication Name Indication ID ICD-11 Status REF
Respiratory syncytial virus infection DIS7FWHY 1C80 Terminated [2]
------------------------------------------------------------------------------------

References

1 Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis. Expert Opin Emerg Drugs. 2009 Sep;14(3):471-9.
2 Emerging drugs for respiratory syncytial virus infection. Expert Opin Emerg Drugs. 2009 Jun;14(2):207-17.